Upgrade to SI Premium - Free Trial

Cantor Fitzgerald Starts MyoKardia (MYOK) at Overweight

October 1, 2018 4:42 AM

Cantor Fitzgerald analyst Alethia Young initiates coverage on MyoKardia (NASDAQ: MYOK) with a Overweight rating and a price target of $90.00.

For an analyst ratings summary and ratings history on MyoKardia click here. For more ratings news on MyoKardia click here.

Shares of MyoKardia closed at $65.20 yesterday.

Categories

New Coverage